IL6 and hepatocellular carcinoma: On the contrary, another study that investigated IL-6 in an Asian HCC cohort showed that pretreatment IL-6 values with a cut-off of 4.58 pg/mL are correlated with overall survival after sorafenib, with high pretreatment levels associated with a poor prognosis (Shao et al. 2017).